TerminatedPhase 1NCT03648437

Paracetamol And Ibuprofen/Indomethacin in Closing Patent Ductus Arteriosus

Studying Arterial duct anomaly

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Oulu
Principal Investigator
Outi Aikio, MD, PhD, MD
Oulu Univerisity Hospital
Intervention
Paracetamol 10Mg/mL(drug)
Enrollment
22 enrolled
Eligibility
All sexes
Timeline
20182024

Study locations (4)

Collaborators

Helsinki University Central Hospital · Turku University Hospital · Tampere University Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03648437 on ClinicalTrials.gov

Other trials for Arterial duct anomaly

Additional recruiting or active studies for the same condition.

See all trials for Arterial duct anomaly

← Back to all trials